Striatal Syntaxin 1A Is Associated with Development of Tourette Syndrome in an Iminodipropionitrile-Induced Animal Model
- PMID: 36157213
- PMCID: PMC9492347
- DOI: 10.1155/2022/1148191
Striatal Syntaxin 1A Is Associated with Development of Tourette Syndrome in an Iminodipropionitrile-Induced Animal Model
Abstract
Tourette syndrome (TS) is a neurodevelopmental movement disorder characterized by multiple motor and vocal tics. In this study, we used a TS rat model induced by 3,3'-iminodipropionitrile (IDPN) and aimed to investigate the expression change of Syntaxin 1A (STX1A). Rats in the control group received intraperitoneal injection of normal saline, and TS rats were injected with IDPN (150 mg/kg/day). After 7 days of treatment, the stereotypic behaviors were assessed. Next, rats were sacrificed; brains were removed for RNA extraction and Western blotting analysis and fixed in 4% paraformaldehyde for immunofluorescence analysis. After 7 days of IDPN administration, stereotypic behaviors were successfully induced. The IDPN group exhibited more counts in biting, putting forepaws around mouth, licking, head twitching, shaking claws, body raising, and episodic utterance. The striatal STX1A mRNA, protein, and STX1A expression in striatal dopaminergic neurons were investigated. As expected, the total STX1A mRNA and protein levels were decreased in the TS model rats. In the striatal dopaminergic neurons, the IDPN group showed a slightly decreased STX1A/TH double positive area, but no statistical significance was found. Additionally, we assessed the expression of some genes closely related to STX1A, such as SNAP25, SY, and gephyrin, and no differences were found between the two groups. Together, reduced STX1A expression is associated with IDPN-induced TS development. Our findings suggested that decreased striatal STX1A expression is associated with the development of TS in the IDPN-induced rat model.
Copyright © 2022 Liu Yang et al.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
The inflammatory injury in the striatal microglia-dopaminergic-neuron crosstalk involved in Tourette syndrome development.Front Immunol. 2023 Apr 28;14:1178113. doi: 10.3389/fimmu.2023.1178113. eCollection 2023. Front Immunol. 2023. PMID: 37187752 Free PMC article.
-
Immune function changes of the IDPN-induced Tourette syndrome rat model.Int J Dev Neurosci. 2021 Apr;81(2):159-166. doi: 10.1002/jdn.10085. Epub 2021 Jan 12. Int J Dev Neurosci. 2021. PMID: 33377196
-
Gastrodin - A potential drug used for the treatment of Tourette Syndrome.J Pharmacol Sci. 2021 Mar;145(3):289-295. doi: 10.1016/j.jphs.2021.01.005. Epub 2021 Jan 20. J Pharmacol Sci. 2021. PMID: 33602510
-
Regulatory effects of Ningdong granule on microglia-mediated neuroinflammation in a rat model of Tourette's syndrome.Biosci Trends. 2020 Sep 21;14(4):271-278. doi: 10.5582/bst.2020.03262. Epub 2020 Jul 31. Biosci Trends. 2020. PMID: 32741856
-
Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats.Int J Neurosci. 1995 Dec;83(3-4):165-75. doi: 10.3109/00207459508986336. Int J Neurosci. 1995. PMID: 8869425 Review.
Cited by
-
The inflammatory injury in the striatal microglia-dopaminergic-neuron crosstalk involved in Tourette syndrome development.Front Immunol. 2023 Apr 28;14:1178113. doi: 10.3389/fimmu.2023.1178113. eCollection 2023. Front Immunol. 2023. PMID: 37187752 Free PMC article.
References
-
- Poulter C., Mills J. Tourette’s syndrome and tic disorders. Innov AiT . 2018;11(7):362–365. doi: 10.1177/1755738017740914. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials